QQQ   276.39 (+1.75%)
AAPL   115.32 (+3.71%)
MSFT   204.72 (+1.01%)
FB   280.83 (+4.92%)
GOOGL   1,556.88 (+3.05%)
AMZN   3,211.01 (+1.52%)
TSLA   410.83 (+1.18%)
NVDA   520.96 (+3.14%)
BABA   312.56 (+1.50%)
CGC   18.78 (+2.40%)
GE   7.37 (-0.67%)
MU   50.48 (+0.96%)
AMD   78.02 (+2.12%)
T   26.76 (+0.98%)
F   7.90 (+2.60%)
ACB   4.09 (+6.79%)
GILD   58.53 (-0.32%)
NFLX   504.21 (+3.70%)
NIO   31.99 (+16.28%)
BA   148.29 (+0.10%)
DIS   121.54 (+2.59%)
QQQ   276.39 (+1.75%)
AAPL   115.32 (+3.71%)
MSFT   204.72 (+1.01%)
FB   280.83 (+4.92%)
GOOGL   1,556.88 (+3.05%)
AMZN   3,211.01 (+1.52%)
TSLA   410.83 (+1.18%)
NVDA   520.96 (+3.14%)
BABA   312.56 (+1.50%)
CGC   18.78 (+2.40%)
GE   7.37 (-0.67%)
MU   50.48 (+0.96%)
AMD   78.02 (+2.12%)
T   26.76 (+0.98%)
F   7.90 (+2.60%)
ACB   4.09 (+6.79%)
GILD   58.53 (-0.32%)
NFLX   504.21 (+3.70%)
NIO   31.99 (+16.28%)
BA   148.29 (+0.10%)
DIS   121.54 (+2.59%)
QQQ   276.39 (+1.75%)
AAPL   115.32 (+3.71%)
MSFT   204.72 (+1.01%)
FB   280.83 (+4.92%)
GOOGL   1,556.88 (+3.05%)
AMZN   3,211.01 (+1.52%)
TSLA   410.83 (+1.18%)
NVDA   520.96 (+3.14%)
BABA   312.56 (+1.50%)
CGC   18.78 (+2.40%)
GE   7.37 (-0.67%)
MU   50.48 (+0.96%)
AMD   78.02 (+2.12%)
T   26.76 (+0.98%)
F   7.90 (+2.60%)
ACB   4.09 (+6.79%)
GILD   58.53 (-0.32%)
NFLX   504.21 (+3.70%)
NIO   31.99 (+16.28%)
BA   148.29 (+0.10%)
DIS   121.54 (+2.59%)
QQQ   276.39 (+1.75%)
AAPL   115.32 (+3.71%)
MSFT   204.72 (+1.01%)
FB   280.83 (+4.92%)
GOOGL   1,556.88 (+3.05%)
AMZN   3,211.01 (+1.52%)
TSLA   410.83 (+1.18%)
NVDA   520.96 (+3.14%)
BABA   312.56 (+1.50%)
CGC   18.78 (+2.40%)
GE   7.37 (-0.67%)
MU   50.48 (+0.96%)
AMD   78.02 (+2.12%)
T   26.76 (+0.98%)
F   7.90 (+2.60%)
ACB   4.09 (+6.79%)
GILD   58.53 (-0.32%)
NFLX   504.21 (+3.70%)
NIO   31.99 (+16.28%)
BA   148.29 (+0.10%)
DIS   121.54 (+2.59%)
Log in
AMEX:EHC

Encompass Health Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume620,391 shs
Average Volume618,344 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others. This segment's hospice services comprise in-home services to terminally ill patients and their families to address patients' physical needs, including pain control and symptom management, and to provide emotional and spiritual support. As of June 15, 2020, Encompass Health Corporation operated 136 hospitals, 245 home health locations, and 83 hospice locations in 39 states and Puerto Rico. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was founded in 1983 and is based in Birmingham, Alabama.
Read More
Encompass Health logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.4Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.48 out of 5 stars

Industry, Sector and Symbol

Industry Medical Care Facilities
Sub-IndustryHealth Care Facilities
SectorMedical
CUSIP42192430
Phone+1-205-9677116
Employees43,300

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings Date2/4/2021 (Estimated)
OptionableOptionable
30 days | 90 days | 365 days | Advanced Chart

Receive EHC News and Ratings via Email

Sign-up to receive the latest news and ratings for EHC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Encompass Health (AMEX:EHC) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Encompass Health?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Encompass Health in the last year. There are currently 1 sell rating, 1 hold rating and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Encompass Health
.

When is Encompass Health's next earnings date?

Encompass Health is scheduled to release its next quarterly earnings announcement on Thursday, February 4th 2021.
View our earnings forecast for Encompass Health
.

How were Encompass Health's earnings last quarter?

Encompass Health Co. (AMEX:EHC) announced its earnings results on Wednesday, October, 28th. The company reported $0.78 EPS for the quarter, beating the Zacks' consensus estimate of $0.75 by $0.03.
View Encompass Health's earnings history
.

How often does Encompass Health pay dividends? What is the dividend yield for Encompass Health?

Encompass Health announced a quarterly dividend on Wednesday, July 22nd. Investors of record on Thursday, October 1st will be paid a dividend of $0.28 per share on Thursday, October 15th. This represents a $1.12 dividend on an annualized basis and a yield of ∞. The ex-dividend date of this dividend is Wednesday, September 30th.
View Encompass Health's dividend history
.

What guidance has Encompass Health issued on next quarter's earnings?

Encompass Health issued an update on its fourth quarter earnings guidance on Wednesday, October, 28th. The company provided EPS guidance of $0.79-0.90 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.93.

What price target have analysts set for EHC?

13 equities research analysts have issued 12-month price objectives for Encompass Health's shares. Their forecasts range from $68.00 to $100.00. On average, they expect Encompass Health's share price to reach $87.86 in the next twelve months.
View analysts' price targets for Encompass Health
.

Who are some of Encompass Health's key competitors?

What other stocks do shareholders of Encompass Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Encompass Health investors own include NVIDIA (NVDA), Gilead Sciences (GILD), Pfizer (PFE), AT&T (T), Walmart (WMT), Netflix (NFLX), Verizon Communications (VZ), AbbVie (ABBV), Activision Blizzard (ATVI) and Chevron (CVX).

Who are Encompass Health's key executives?

Encompass Health's management team includes the following people:
  • Mr. Mark J. Tarr, CEO, Pres & Director (Age 58, Pay $2.77M)
  • Mr. Douglas E. Coltharp, Exec. VP & CFO (Age 58, Pay $1.56M)
  • Mr. John Patrick Darby, Exec. VP, Gen. Counsel & Corp. Sec. (Age 55)
  • Ms. Barbara Ann Jacobsmeyer, Exec. VP & Pres of Inpatient Hospitals (Age 54)
  • Ms. April Kaye-Bullock Anthony, Chief Exec. Officer of Home Health & Hospice (Age 53, Pay $523.41k)

What is Encompass Health's stock symbol?

Encompass Health trades on the AMEX under the ticker symbol "EHC."

How do I buy shares of Encompass Health?

Shares of EHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Encompass Health's official website?

The official website for Encompass Health is www.healthsouth.com.

How can I contact Encompass Health?

Encompass Health's mailing address is 3660 Grandview Pkwy Ste 200, BIRMINGHAM, AL 35243-3332, United States. The company can be reached via phone at +1-205-9677116 or via email at [email protected]

This page was last updated on 10/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.